The 2009 LCGC Awards
LCGC North America
LCGC hands out a pair of awards at Pittcon 2009 in Chicago.
LCGC North America handed out its annual awards at Pittcon 2009 in Chicago, Illinois this year, at a press conference held on Monday, March 9 in the McCormick Place Convention Center. On hand were many members of the chromatography community, including presenters Robert Classon of Shimadzu and Ron Majors of Agilent Technologies.
The awards themselves were the same as last year, with an Emerging Leader Award presented to the scientist making the greatest strides at an early stage of his or her career and a Lifetime Achievement Award presented to an industry veteran whose career has significantly influenced and advanced the field of separation science.
The 2009 Emerging Leader Award went to Kevin Schug, an assistant professor at the University of Texas at Arlington, where he leads a group of nine researchers whose work focuses primarily on LC–MS research, specifically ESI-MS/HPLC.
Winners of the LCGC Emerging Leader Award
This year's Lifetime Achievement Award went to a well known figure in the world of analytical chemistry, Harold McNair, professor emeritus of Virginia Tech's chemistry department. Dr. McNair has been active in the field for over 50 years, with a lengthy list of awards and accomplishments on his resume. Most recently, he won the Horvath Medal in 2003 and the EAS Award in Analytical Chemistry in 2004.
Winners of the LCGC Lifetime Achievement Award
LCGC extends its warmest congratulations to this year's award winners and thanks everyone who participated whether by voting, submitting nominations, or contributing a recommendation for a candidate.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
